Back
December 1, 2021

From an immunological point of view, boosters and mass vaccination are as harmful as mold on a wall

Q&A with Geert Vanden Bossche #1

Question:
Should vaccinated people go get their booster shots or not?

Answer:
From an immunological point of view, boosters and mass vaccination in general are as harmful as mold on a wall.

The vaccine can not prevent infection nor transmission. By again increasing the antibodies (with the booster), the virus is put under an even higher immune pressure while further expanding its capacity to escape from the vaccinal antibodies (Abs). As a result more infectious variants gain a competitive advantage and hence, will spread stronger amongst the population. This only precipiates and expands the evolutionary capacity of the virus to resist the vaccines. The level of protection WHO has recently been claiming (40%) is anything but due to the vaccines and can only be ascribed to some ‘trained’ innate immunity large parts of the population acquired prior to vaccination as a result of asymptomatic/ mild infection. It is crystal clear, indeed, that none of the C-19 vaccines is capable of blocking transmission, not even by 1 % ! Because vaccinal Abs suppress relevant innate Abs, these vaccines have no capacity whatsoever to confer sterilizing immunity. Consequently, none of these vaccines help to build herd immunity; on the contrary, they generate a breeding ground in vaccinees for more infectious variants, thereby further increasing infection rates and threatening both the unvaccinated and vaccinated. Moreover, vaccinal Abs tend to outcompete innate Abs for binding to SARS-CoV-2 because of their higher affinity for the virus. This particularly applies to naive innate Abs (children!) and already explains why C-19 vaccination is at risk of dramatically weakening people’s first line of immune defense, especially in children. Our innate immunity is not only well armed to protect against COVID-19 (including all its variants!), but also against a number of other viruses causing acute respiratory disease.

There can be no doubt, therefore, that such an assault of our immune system will have dramatic consequences on both individual and public health. Basically, mass vaccination is now turning Covid-19 into a disease of young and healthy unvaccinated people while enabling the virus to break through both the innate and adaptive immune defense of vaccinees due to vaccine-mediated suppression of innate Abs and viral resistance to vaccinal Abs, respectively. For those who didn’t get it thus far, Omicron will repeat that lesson; its teaching will only be a bit tougher and will soon silence all those who are trying to convince their people that they can outsmart the virus and, as they ridiculously claim, ‘stay ahead of the virus’.

Support our work
DONATE
Subscribe to our Substack Newsletter

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.

Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.

Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.

Email: info@voiceforscienceandsolidarity.org

Recent Posts
December 2, 2024

Are Newly Emerging Saltation Variants the Desperate Harbingers of an Imminent Surge in COVID-19 Case Fatalities in Highly C-19 Vaccinated Populations?

Read
November 23, 2024

Bird Flu Gain-of-Function Study Fueling Vaccine Development, Fears of Human Transmission

Read
November 23, 2024

De kak van Knack

Read
Voices for Science and solidarity, © 2023